TabsDetailsBasic DetailsDate Posted: Monday, January 13, 2020Status: CompleteMedical Product: metoclopramide HCLHealth Outcome(s): diabetic gastroparesistype 2 diabetes mellitusDescription: The goal of this query was to examine utilization of metoclopramide among female members without evidence of liveborn delivery with type 2 diabetes. We also examined female members without evidence of liveborn delivery with a combination of type 2 diabetes and diabetic gastroparesis in the Sentinel Distributed Database (SDD). Data from January 1, 2008 - September 30, 2015 from 17 Data Partners who contributed to the SDD were included in this report. This request was distributed on May 24, 2018. Read More Deliverables (1)Sentinel Modular Program Report: Use of Metoclopramide among Patients with Diabetic Gastroparesis and Type 2 DiabetesAdditional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2008 - September 30, 2015Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: Females 40 years of age and olderData Sources: Sentinel Distributed Database (SDD)
